|
Sign In to gain access to subscriptions and/or personal tools.
|
Persistent effect of treatment with candesartan cilexetil on blood pressure in spontaneously hypertensive rats
Karin Skov
Department of Pharmacology, University of Aarhus, Aarhus, Denmark
Susie Mogensen
Department of Pharmacology, University of Aarhus, Aarhus, Denmark
Michael J Mulvany
Department of Pharmacology, University of Aarhus, Aarhus, Denmark, mm{at}farm.au.dk
We have investigated whether the angiotensin II type-1 (AT1) receptor antagonist, candesartan cilexetil, has a persistent effect on blood pressure even after withdrawal of treatment, as has been shown consistently for angiotensin-converting enzyme inhibitors (ACE-1). Spontaneously hypertensive rats (SHR) were divided into four groups (n=16 per group) and treated with candesartan cilexetil (high-dose: 5 mg/kg/day; middle-dose: 1 mg/kg/day; low-dose: 0.5 mg/kg/day) or control from age four weeks to 20 weeks. Normotensive Wistar-Kyoto rats (WKY) were also investigated. The drug was given in the drinking water, the concentration adjusted for water consumption and rat weight. Blood pressure (BP) was measured regularly by the indirect tail-cuff method during the treatment period and after treatment, from age 20 weeks to 32 weeks.
At age 20 weeks, candesartan treatment had caused a slight reduction in body weight, an increase in water consumption and a reduction in heart rate. During treatment, candesartan caused a dose-dependent reduction in BP. After withdrawal of treatment, BP increased but remained lower than that of untreated control SHR for the medium- and high-dose groups throughout the follow-up period, the reduction being 8—11% at the end of follow-up. At age 32 weeks, there was no significant difference between the three candesartan-treated groups.
We conclude that treatment with the AT1-receptor antagonist candesartan has a modest persistent effect on BP after withdrawal of treatment.
Key Words: persistent antihypertensive effect spontaneously hypertensive rat withdrawal of treatment
References
- Guidicelli JF, Freslon JL, Glasson S., Richer C. Captopril and hypertension development in the SHR. Clinical and Experimental Hypertension 1980;2:1083-96.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Christensen KL, Jespersen LT, Mulvany MJ Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to resistance vessel structure. J Hypertens 1989;7:83-90.[Medline]
[Order article via Infotrieve]
- Harrap SB, Merwem WMV, Griffin SA, Macpherson F., Lever AF Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.Hypertension 1990;16:603-14.[Abstract/Free Full Text]
- Thybo NK, Korsgaard N., Eriksen S., Christensen KL, Mulvany MJ Dose-dependent effects of perindopril on blood pressure and on small artery structure. Hypertension 1994;23:659-66.[Abstract/Free Full Text]
- Skov K., Fenger Gron J., Mulvany MJ Effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist, and an endothelin receptor antagonist on renal afferent arteriolar structure. Hypertension 1996;28:464-71.[Abstract/Free Full Text]
- Notoya M., Nakamura M., Mizojiri K. Effects of lisinopril on the structure of renal arterioles. Hypertension 1996;27:364-70.[Abstract/Free Full Text]
- Harrap SB Angiotensin converting enzyme inhibitors, regional vascular hemodynamics, and the development and prevention of experimental genetic hypertension. Am J Hypertens 1991;4:212S-216S.[Medline]
[Order article via Infotrieve]
- Morton JJ, Beattie EC, Macpherson F. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. J Vasc Res 1992;29:264-9.[Web of Science][Medline]
[Order article via Infotrieve]
- Gillies LK, Lu M.,Wang H., Lee RM AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats. Hypertension 1997;30:1471-8.[Abstract/Free Full Text]
- Cervenka L.,Wang CT, Navar LG Effects of acuteAT1 receptor blockade by candesartan on arterial pressure and renal function in rats. AmJPhysiol 1998;274:F940-F945.[Web of Science][Medline]
[Order article via Infotrieve]
- Nishiyama K., Nishiyama A., Frohlich ED Regional blood flow in normotensive and spontaneously hypertensive rats.Am J Physiol 1976;230:691-8.[Abstract/Free Full Text]
- Skov K., Mulvany MJ, Korsgaard N. Renal afferent arterioles in spontaneously hypertensive rats investigated by a new perfusion technique.Hypertension 1992;20:821-7.[Abstract/Free Full Text]
- Gattone VH, EvanAP, Willis LR, Luft FC Renal afferent arteriole in the spontaneously hypertensive rat. Hypertension 1983;5:8-16.[Abstract/Free Full Text]
- Norrelund H., Christensen KL, Samani NJ, Kimber P., Mulvany MJ, Korsgaard N. Decreased afferent arteriole diameter is a predictor for development of high blood pressure in F-2-generation hypertensive/normotensive rats. Hypertension 1994;24:301-8.[Abstract/Free Full Text]
- Rettig R., Folberth CG, Stauss H., Kopf D., Waldherr R., Baldauf G., Unger T. Hypertension in rats induced by renal grafts from renovascular hypertensive donors. Hypertension 1990;15:429-35.[Abstract/Free Full Text]
- Heller J., Schubert G., Havlickova J.,Thurau K. The role of the kidney in the development of hypertension: a transplantation study in the Prague hypertensive rat. Pflugers Arch 1993;425:208-12.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Grisk O., Rose HJ, Rettig R. The development of post-transplantation hypertension in recipients of an SHR kidney is independent of reinnervation of the graft. Pflugers Arch 1999;438:502-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- UngerT., Ganten D., Lang RE, Scholkens BA Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats.J Cardiovasc Pharmacol 1985;7:36-41.[Web of Science][Medline]
[Order article via Infotrieve]
- O'Sullivan JB, Harrap SB Resetting blood pressure in spontaneously hypertensive rats. The role of bradykinin. Hypertension 1995;25:162-5.[Abstract/Free Full Text]
- Charchar FJ, Kapuscinski M., Harrap SB Persistent reduction in renal nerve growth factor mRNA after perindopril treatment of young spontaneously hypertensive rats. Hypertension 1998;31:678-83.[Abstract/Free Full Text]
- Dukacz SA, Adams MA, Kline RL Short- and long-term enalapril affect renal medullary hemodynamics in the spontaneously hypertensive rat. Am J Physiol 1999;276:R10-R16.[Web of Science][Medline]
[Order article via Infotrieve]
- Sorensen CM, Leyssac PP, Skott O., Holstein-Rathlou NH Role of the renin-angiotensin system in regulation and autoregulation of renal blood flow. Am J Physiol 2000; Sep;279(3):R1017-R1024[Web of Science]
- Christensen KL Studies on location of resistance arteries, changes in their morphology during antihypertensive therapy and post-treatment blood pressure recovery (doctoral thesis), Aarhus, Medical Faculty, University ofAarhus, 2000,
- Bushfield T., Hale T., Adams M. Persistent lowering of pressure following ACE-inhibiton treatment is not dependent on the kallikrein-kinin system. J Hypertens 2000;18(suppl 4):s85(abstract)
- Mulvany MJ, Persson AE, Andresen J. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure. J Hypertens 1991;9:589-93[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- van Hooft IM, Grobbee DE, Derkx FH, de Leeuw PW, Schalekamp MA, Hofman A. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med 1991;324:1305-11.[Abstract]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 1 suppl,
S91-S94 (2001)
DOI: 10.1177/14703203010020011601

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|